lp-10
Generic: tacrolimus
lp-10: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| LIPELLA PHARMACEUTICALS INC. (LIPO) | Phase 2 |
Clinical Trials (1)
A Multicenter, Dose-Ranging Trial Evaluating the Safety, Tolerability, and Efficacy of LP-10 in Subjects With Symptomatic Oral Lichen Planus
Frequently asked questions
Who is developing lp-10?
lp-10 is being developed by LIPELLA PHARMACEUTICALS INC..
How many clinical trials involve lp-10?
BioSniper tracks 1 clinical trial involving lp-10.
Get deeper analysis on lp-10
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis